Trending/FDA
New Alzheimer’s drug to be submitted to FDA for approval
Drug company Biogen Inc. intends to pursue regulatory approval from the Food and Drug Administration (FDA) for their experimental Alzheimer's drug, aducanumab, based on new…
October 20, 2017
Mayo Clinic Minute: A warning about Halloween costume contacts
July 13, 2017
June 5, 2017
April 21, 2017
September 6, 2016
No more over-the-counter antibacterial wash with certain ingredients
Special Topics
Sign up
Social Media Network
A network for digital healthcare communicators
Mayo Clinic Connect
An online patient support community